rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    FMS
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Dialysis Giants DaVita and Fresenius Blocking Competition In Washington, Lawsuit Accuses
      Nov 12BenzingaDVAFMS
      Fresenius SE cuts Fresenius Medical Care stake to 20%

      Fresenius Medical Care (FMS) stock gains as parent Fresenius SE (FSNUF) (FSNUY) cuts its stake to ~20% from ~25%. Read more here.

      Nov 12Seeking AlphaFMS
      Washington state accuses largest dialysis providers DaVita, Fresenius of suppressing competition
      Nov 10ReutersDVAFMS
      Barclays sees Fresenius Medical Care earnings hit by reimbursement pressures
      Nov 9Yahoo FinanceBCSFMS
      Fresenius Medical Care AG (FMS) (Q3 2026) Earnings Call Highlights: Stable Revenue, 5008X ...
      Nov 6Yahoo FinanceFMS
      Fresenius raises 2026 earnings outlook after Q3 profit beats estimates
      Nov 4Yahoo FinanceFMS
      What Fresenius Medical Care AG & Co. KGaA (FMS) Said on Its Q3 Earnings Call
      Nov 4Yahoo FinanceFMS
      Fresenius Medical Care AG & Co. KGaA Q3 2026 Earnings Call Summary
      Nov 4Yahoo FinanceFMS
      Fresenius Medical Care Q3 2026 Earnings Call Transcript
      Nov 3BenzingaFMS
      Fresenius Medical Care ADR earnings beat by $0.65, revenue fell short of estimates
      Nov 3Investing.comFMS
      Fresenius Medical Care (XTRA:FME) Stock May Trade Below Fair Value On Its FDA Cleared AKI System Launch
      Nov 3Yahoo FinanceFMS
      Fresenius Medical Care stock rises 2% on earnings beat despite revenue miss
      Nov 3Investing.comFMS
      Why is Fresenius Medical Care stock rallying today?
      Nov 3Investing.comFMS
      Fresenius Medical Care Q3 Adjusted Earnings, Revenue Rise; Shares Up Pre-Bell
      Nov 3Yahoo FinanceFMS
      Fresenius Medical Care cuts outlook despite Q3 beat
      Nov 3Investing.comFMS
      Fresenius: Q3 Earnings Snapshot
      Nov 3Yahoo FinanceFMS
      Fresenius Medical cuts top end of 2026 profit outlook
      Nov 3ReutersFMS
      Fresenius: 'We are doubling down on our biopharma business'
      Nov 2Yahoo FinanceFMS
      Watchdog places Scarborough dialysis unit in special measures

      The Care Quality Commission rates Scarborough dialysis unit inadequate after finding failings.

      Oct 28BBCFMS
      Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from J.P. Morgan

      Detailed price information for Fresenius Medical Care Ag ADR (FMS-N) from The Globe and Mail including charting and trades.

      Oct 24The Globe and MailFMS
      FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI
      Oct 23Yahoo FinanceFMS
      UBS Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

      Detailed price information for Fresenius Medical Care Ag ADR (FMS-N) from The Globe and Mail including charting and trades.

      Oct 21The Globe and MailFMS
      DaVita, Fresenius drop as HHS seeks dialysis market reforms (DVA:NYSE)
      Oct 20Seeking AlphaDVAFMS
      Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold from Deutsche Bank

      Detailed price information for Fresenius Medical Care Ag ADR (FMS-N) from The Globe and Mail including charting and trades.

      Oct 20The Globe and MailFMS
      Truist Trims Price Target on Fresenius Medical Care to $24 From $25, Keeps Hold Rating
      Oct 12Yahoo FinanceFMS
      Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from J.P. Morgan

      Detailed price information for Fresenius Medical Care Ag ADR (FMS-N) from The Globe and Mail including charting and trades.

      Oct 8The Globe and MailFMS
      Fresenius Medical Care Names Shervin Korangy CEO as Transformation Phase Gives Way to Growth

      Detailed price information for Fresenius Medical Care Ag ADR (FMS-N) from The Globe and Mail including charting and trades.

      Oct 8The Globe and MailFMS
      Fresenius Medical Care names Korangy as new chief executive
      Oct 8Yahoo FinanceFMS
      Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now

      FMS' transformation is lifting profitability, while HDF, value-based care and cost savings offset volume and reimbursement pressures.

      Oct 7Yahoo FinanceFMS
      Why is Fresenius Medical Care ADR stock sliding today?
      Oct 7Investing.comFMS
      Fresenius Medical Care tumbles on CEO transition announcement
      Oct 7Investing.comFMS
      Fresenius Medical Care names Shervin Korangy as new CEO
      Oct 7Investing.comFMS
      Fresenius Medical Care Names Shervin Korangy as CEO, Board Chair
      Oct 7Yahoo FinanceFMS
      Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth

      BAD HOMBURG, Germany, Oct. 7, 2026/ PRNewswire/-- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced that Shervin J. Korangy will become Chief Executive Officer and Chair of the Management Board, effective October 12, 2026. The Supervisory Board unanimously appointed him to succeed...

      Oct 7NasdaqFMS
      Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth – Company Announcement - FT.com
      Oct 7Financial TimesFMS
      Fresenius Medical Care: Margin Expansion Supports The Story, Growth Remains Limited (FMS)

      Fresenius Medical Care is improving operationally, with Q2 2026 organic revenue up 5% and adjusted operating profit up 23%. Read why FMS stock is a hold.

      Oct 7Seeking AlphaFMS
      Fresenius Kabi Receives Pharmacy Strategic Programs Excellence Award From Vizient®
      Sep 30Yahoo FinanceFMS
      Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth

      FMS refines its China strategy around advanced dialysis and critical-care technologies, with 110M euros in one-time costs.

      Sep 29Yahoo FinanceFMS
      Berenberg downgrades Fresenius Medical Care stock rating to hold
      Sep 29Investing.comFMS
      Berenberg Downgrades Fresenius Medical Care to Hold From Buy, Cuts Price Target to $24 From $34.50
      Sep 29Yahoo FinanceFMS
      Fresenius Medical Care Refines China Strategy With Targeted Product Focus - Fresenius Medical Care (NYSE:

      Fresenius Medical Care updates China strategy, and incurs a 110 million euro charge while focusing on advanced dialysis tech.

      Sep 25BenzingaFMS
      Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business

      Fresenius Medical Care (FMS) said Friday it has refined its China commercial strategy, with plans to

      Sep 25Yahoo FinanceFMS
      FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk

      The U.S. Food and Drug Administration (FDA) on Tuesday issued a warning letter to Fresenius Medical Care AG & Co. KGaA’s Fresenius USA Manufacturing following a March 2026 inspection at its Ogden, Utah production facility. In a letter to the...

      Sep 7Yahoo FinanceFMS
      FDA Slams Fresenius Over Leaking Dialysis Bags - Fresenius Medical Care (NYSE:FMS)
      Sep 4BenzingaFMS
      Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?

      Fresenius Medical is scaling its 5008X rollout across U.S. clinics, creating growth potential despite volume, reimbursement and rollout-cost pressures.

      Sep 3Yahoo FinanceOMFMS
      Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now

      Fresenius Medical's improving profitability, 5008X rollout and value-based care gains offer support despite volume and reimbursement risks.

      Sep 3Yahoo FinanceFMS
      Fresenius Medical Care: Time To Buy This High-Yield Dividend Aristocrat (NYSE:FMS)
      Aug 22Seeking AlphaFMS

      This is the newest page. Registered accounts read further back.